Related Experiment Videos
Pathology quiz case: Plasmacytoid dendritic cell neoplasm.
Quinn A Dunlap1, Kristine E Day, Samuel G Borak
1Department of Surgery, Division of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Allergy & Rhinology (Providence, R.I.)
|September 9, 2014
Summary
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) can present unusually as a paranasal sinus tumor. Early diagnosis via flow cytometry and immunohistochemistry is crucial for this rare malignancy.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy.
- BPDCN typically presents with heterogeneous clinical and immunophenotypic features.
- Its exact origin remains a subject of debate.
Purpose of the Study:
- To report a unique case of BPDCN presenting as a primary paranasal sinus tumor.
- To emphasize the diagnostic challenges and heterogeneity of BPDCN.
- To highlight the importance of early diagnosis and appropriate diagnostic modalities.
Main Methods:
- Case report detailing a patient with BPDCN.
- Review of diagnostic modalities including flow cytometry and immunohistochemistry.
- Discussion of clinical presentation and literature review.
Main Results:
- A case of BPDCN presenting solely as a primary paranasal sinus tumor was identified.
- The patient had no evidence of cutaneous or systemic involvement.
- This presentation expands the known spectrum of BPDCN manifestations.
Conclusions:
- BPDCN can manifest atypically, even without bone marrow, blood, or skin involvement.
- Flow cytometry and immunohistochemistry are essential for diagnosing unusual BPDCN presentations.
- Early diagnosis is critical for timely treatment initiation and improved patient outcomes.